These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 34638984)

  • 1. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions.
    La Sala L; Pontiroli AE
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trial.
    Battelino T; Tehranchi R; Bailey T; Dovc K; Melgaard A; Yager Stone J; Woerner S; von dem Berge T; DiMeglio L; Danne T
    Pediatr Diabetes; 2021 Aug; 22(5):734-741. PubMed ID: 33934456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dasiglucagon: an effective medicine for severe hypoglycemia.
    Xu B; Tang G; Chen Z
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1783-1790. PubMed ID: 34223944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Use of Intranasal Glucagon: Resolution of Hypoglycemia.
    Pontiroli AE; Tagliabue E
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31349701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog.
    Hövelmann U; Bysted BV; Mouritzen U; Macchi F; Lamers D; Kronshage B; Møller DV; Heise T
    Diabetes Care; 2018 Mar; 41(3):531-537. PubMed ID: 29273578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal glucagon: a promising approach for treatment of severe hypoglycemia.
    Pontiroli AE
    J Diabetes Sci Technol; 2015 Jan; 9(1):38-43. PubMed ID: 25385946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?
    Pontiroli AE; Ceriani V
    Diabetes Obes Metab; 2018 Aug; 20(8):1812-1816. PubMed ID: 29652110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal versus injectable glucagon for hypoglycemia in type 1 diabetes: systematic review and meta-analysis.
    Pontiroli AE; Tagliabue E
    Acta Diabetol; 2020 Jun; 57(6):743-749. PubMed ID: 32025860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating dasiglucagon as a treatment option for hypoglycemia in diabetes.
    Li S; Hu Y; Tan X; Wang D; Hu J; Zou P; Wang L
    Expert Opin Pharmacother; 2020 Aug; 21(11):1311-1318. PubMed ID: 32267182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dasiglucagon-A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical Trial.
    Pieber TR; Aronson R; Hövelmann U; Willard J; Plum-Mörschel L; Knudsen KM; Bandak B; Tehranchi R
    Diabetes Care; 2021 Jun; 44(6):1361-1367. PubMed ID: 35239971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Usability of Intranasal Glucagon for the Management of Hypoglycemia in Patients With Diabetes: A Systematic Review.
    Singh-Franco D; Moreau C; Levin AD; Rosa D; Johnson M
    Clin Ther; 2020 Sep; 42(9):e177-e208. PubMed ID: 32873417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dasiglucagon demonstrates reduced costs in the treatment of severe hypoglycemia in a budget impact model.
    Hinahara J; Weinzimer SA; Bromley ER; Goss TF; Kendall DM; Hammer M
    J Manag Care Spec Pharm; 2022 Apr; 28(4):461-472. PubMed ID: 35332789
    [No Abstract]   [Full Text] [Related]  

  • 13. Intranasal glucagon treatment relieves hypoglycaemia in children with type 1 (insulin-dependent) diabetes mellitus.
    Stenninger E; Aman J
    Diabetologia; 1993 Oct; 36(10):931-5. PubMed ID: 8243872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setting.
    Deeb LC; Dulude H; Guzman CB; Zhang S; Reiner BJ; Piché CA; Pradhan S; Zhang XM
    Pediatr Diabetes; 2018 Aug; 19(5):1007-1013. PubMed ID: 29512902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus.
    Hövelmann U; Olsen MB; Mouritzen U; Lamers D; Kronshage B; Heise T
    Diabetes Obes Metab; 2019 Mar; 21(3):601-610. PubMed ID: 30350477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon.
    GhavamiNejad A; Li J; Lu B; Zhou L; Lam L; Giacca A; Wu XY
    Adv Mater; 2019 Jul; 31(30):e1901051. PubMed ID: 31165524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes.
    Sherr JL; Ruedy KJ; Foster NC; Piché CA; Dulude H; Rickels MR; Tamborlane WV; Bethin KE; DiMeglio LA; Fox LA; Wadwa RP; Schatz DA; Nathan BM; Marcovina SM; Rampakakis E; Meng L; Beck RW;
    Diabetes Care; 2016 Apr; 39(4):555-62. PubMed ID: 26884472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes.
    Wendt SL; Ranjan A; Møller JK; Schmidt S; Knudsen CB; Holst JJ; Madsbad S; Madsen H; Nørgaard K; Jørgensen JB
    J Diabetes Sci Technol; 2017 Nov; 11(6):1101-1111. PubMed ID: 28654314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal Glucagon Versus Injectable Glucagon for Severe Hypoglycemia: A Cost-Offset and Budget Impact Analysis.
    Pöhlmann J; Mitchell BD; Bajpai S; Osumili B; Valentine WJ
    J Diabetes Sci Technol; 2019 Sep; 13(5):910-918. PubMed ID: 30700165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dasiglucagon for treating severe hypoglycemia in patients with diabetes.
    Ju Y; Zhang D; Yang J
    Expert Rev Clin Pharmacol; 2022 Jul; 15(7):799-803. PubMed ID: 35848442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.